Protein C Pathway, Antiphospholipid Antibodies and Thrombosis
- 1 August 1994
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 3 (4) , 229-233
- https://doi.org/10.1177/096120339400300405
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Autoantibodies directed against the epidermal growth factor‐like domains of thrombomodulin inhibit protein C activation in vitroBritish Journal of Haematology, 1993
- Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.Journal of Clinical Investigation, 1993
- Role of beta 2-glycoprotein I and anti-phospholipid antibodies in activation of protein C in vitro.Journal of Clinical Pathology, 1993
- Monoclonal Autoantibodies to Cardiolipin Derived from SLE MiceLupus, 1992
- Concurrent protein C deficiency and lupus anticoagulantsAmerican Journal of Hematology, 1992
- Letter to the editor: Spurious protein C deficiency due to antiphospholipid antibodiesAmerican Journal of Hematology, 1991
- Transient anticardiolipin antibodies, functional protein S deficiency, and deep vein thrombosisAmerican Journal of Hematology, 1991
- Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactorThe Lancet, 1990
- Risk factors for thrombosis in lupus patients.Annals of the Rheumatic Diseases, 1989
- Modulation of endothelial cell hemostatic properties by tumor necrosis factor.The Journal of Experimental Medicine, 1986